Gotham Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-82,432
Closed -$1.54M 1820
2025
Q2
$1.54M Buy
82,432
+13,803
+20% +$273K 0.01% 1020
2025
Q1
$1.31M Sell
68,629
-47,247
-41% -$1.38M 0.01% 921
2024
Q4
$4.17M Sell
115,876
-4,430
-4% -$150K 0.04% 549
2024
Q3
$5.1M Sell
120,306
-10,415
-8% -$442K 0.05% 483
2024
Q2
$5.27M Buy
130,721
+7,469
+6% +$312K 0.07% 414
2024
Q1
$4.36M Buy
123,252
+47,979
+64% +$1.29M 0.07% 413
2023
Q4
$2.23M Buy
75,273
+60,555
+411% +$1.26M 0.04% 567
2023
Q3
$306K Sell
14,718
-129,494
-90% -$3.56M 0.01% 1115
2023
Q2
$3.54M Buy
144,212
+79,646
+123% +$2.56M 0.08% 364
2023
Q1
$2.62M Buy
64,566
+20,806
+48% +$861K 0.06% 417
2022
Q4
$1.97M Buy
43,760
+34,763
+386% +$1.57M 0.06% 434
2022
Q3
$431K Sell
8,997
-5,008
-36% -$275K 0.01% 883
2022
Q2
$829K Buy
14,005
+588
+4% +$48.3K 0.03% 634
2022
Q1
$1.56M Buy
13,417
+6,644
+98% +$776K 0.05% 422
2021
Q4
$1.02M Buy
+6,773
New +$914K 0.03% 531
2021
Q3
Sell
-2,566
Closed -$250K 1119
2021
Q2
$250K Buy
+2,566
New +$229K 0.01% 898
2019
Q4
Sell
-3,464
Closed -$204K 1212
2019
Q3
$204K Sell
3,464
-5,982
-63% -$382K ﹤0.01% 1011
2019
Q2
$609K Sell
9,446
-11,573
-55% -$747K 0.01% 743
2019
Q1
$1.33M Buy
21,019
+505
+2% +$26.5K 0.02% 582
2018
Q4
$779K Buy
+20,514
New +$724K 0.01% 683

Other funds holding TNDM

Gotham Asset Management's TNDM Position: Q3 2025 in Review

Gotham Asset Management sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 82,432 shares — an estimated $1.54M sold.

Gotham Asset Management first reported a position in TNDM in Q4 2018 and held it in 20 quarters. The position peaked at $5.27M in Q2 2024. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Gotham Asset Management reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Gotham Asset Management sold 82,432 Tandem Diabetes Care shares in Q3 2025, an estimated $1.54M.
  • Gotham Asset Management first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 20 quarters.
  • Gotham Asset Management's Tandem Diabetes Care position peaked at $5.27M in Q2 2024.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Gotham Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.